Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

This study has been completed.
Information provided by National Institute on Aging (NIA)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Alzheimer Disease
2		More general conditions related to this trial
			Brain Diseases
			Central Nervous System Diseases
			Delirium, Dementia, Amnestic, Cognitive Disorders
			Dementia
			Mental Disorders
			Nervous System Diseases
			Neurodegenerative Diseases
			Tauopathies
3		Interventions listed in this trial
			Naproxen Sodium (Aleve)
			Celecoxib (Celebrex)
4		Additional drug interventions recognized in this trial
			Naproxen
5		More general drug interventions related to this trial
			Analgesics
			Analgesics, Non-Narcotic
			Anti-Inflammatory Agents
			Anti-Inflammatory Agents, Non-Steroidal
			Antirheumatic Agents
			Central Nervous System Agents
			Cyclooxygenase Inhibitors
			Enzyme Inhibitors
			Gout Suppressants
			Molecular Mechanisms of Pharmacological Action
			Peripheral Nervous System Agents
			Pharmacologic Actions
			Physiological Effects of Drugs
			Sensory System Agents
			Therapeutic Uses
6		Sponsors listed in this trial
			National Institute on Aging (NIA)
			Department of Veterans Affairs
			University of Washington
			Johns Hopkins University